SPARROW-QUANTUM
14.3.2024 08:06:34 CET | Business Wire | Press release
ORCA Computing, Pixel Photonics, Sparrow Quantum, and the Niels Bohr Institute (NBI) announce their collaboration on the Eurostars project 'SupremeQ.' This landmark initiative brings together quantum experts from the United Kingdom, Germany, and Denmark with a shared goal of accelerating the development and commercialization of photonic quantum computing technologies to deliver quantum advantage.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313844049/en/
ORCA PT-1 computer in assembly room (Photo: Business Wire)
Supported by Eurostars, a European funding program dedicated to assisting R&D-performing SMEs in developing marketable innovative products, processes, and services, the SupremeQ project will harness world-leading expertise. It will draw upon single-photon sources from Sparrow Quantum and NBI, single-photon detectors from Pixel Photonics, and full-stack photonic quantum computing system architecture from ORCA Computing. By uniting efforts, the SupremeQ consortium aims to drive breakthrough innovation in photonic quantum computing, paving the way for quantum advantage.
According to a report by Fortune Business Insights, the quantum computing market is forecasted to reach $6.5 billion by 2030 with a CAGR of 32.1%1. With a broad range of potential application areas offering significant advantages over current classical computations. The SupremeQ project aims to address the needs of this growing market demand for quantum computing capabilities by addressing key challenges such as system engineering for scale, high acquisition, and operation costs, as well as the need for specialized expertise.
By pioneering solutions for photonic quantum computing, the project aims to unveil groundbreaking innovations in performance, packaging, and system integration. Sparrow Quantum’s single-photon sources and Pixel Photonics detectors will be engineered to co-exist within a single cryostat, marking a breakthrough in quantum computing infrastructure. With reduced complexity and enhanced component proximity, this crucial milestone heralds the path to multiplying qubits while offering considerable manufacturability and cost advantages.
ORCA Computing will draw upon its deep knowledge in quantum photonic system architecture. This expertise will be used to integrate these developments and demonstrate state-of-the-art photon processing efficiencies and reconfigurability within a standard data center rack.
These advancements are necessary for the commercialization of quantum computers to reach advantage over classical computing systems signifying a significant leap toward achieving universal fault-tolerant quantum computing.
As the quantum computing market continues to evolve, the consortium is confident that their innovative SupremeQ solutions will generate considerable interest, driving diverse applications and accelerating the widespread adoption of quantum technologies across industries well beyond the conclusion of the Eurostars program.
Consortium partners share their perspectives on the groundbreaking developments of the project:
"I envision SupremeQ as a symphony of quantum brilliance, with each partner playing a unique instrument,” stated Dr. Kurt Stokbro, CEO of Sparrow Quantum. “Together, we're composing a masterpiece that I believe will make some noise around the world."
"The advancements made possible through the SupremeQ project represent a significant leap forward in quantum computing technology," stated Nicolai Walter, CEO of Pixel Photonics. "By combining cutting-edge components and innovative architecture, we will be well-positioned to redefine the boundaries of what is possible in quantum computing."
"We are delighted to announce this new partnership with two other leading European firms,” affirmed Richard Murray, CEO of ORCA Computing. "With its unparalleled performance, the outcome of this project will spearhead new frontiers in hybrid quantum-classical computation, driving significant advancements in machine learning and optimization."
“We are thrilled to collaborate with esteemed industry partners on the SupremeQ project, which represents a significant step forward in quantum computing innovation," says Peter Lodahl, Professor at the Niels Bohr Institute.
Explore the SupremeQ project and how it will revolutionize the industry by contacting the consortium partners for more information.
Source 1: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/quantum-computing-market-104855
About ORCA Computing:
ORCA Computing, headquartered in London, UK with offices in the United States and Canada, is a leading developer and provider of full-stack photonic quantum computing systems. Established in 2019 and originating from the University of Oxford, the company provides an innovative approach to photonic quantum computing. Anchored in a modular optical fiber-based architecture, ORCA’s proprietary methods of manipulating the time, frequency and switching of single photons paves the way for quantum computing using significantly fewer components. ORCA Computing has successfully delivered numerous on-premises quantum computers to leading customers including the UK Ministry of Defence and the Poznan Supercomputing and Networking Center.
For more information, please visit www.orcacomputing.com.
About Pixel Photonics:
Pixel Photonics is a German deep-tech startup that has developed a unique approach to integrate SNSPDs (Superconducting Nanowire Single Photon Detectors) on a chip waveguide. Pixel Photonics combines the superior features of SNSPDs with the versatility of an integrated photonic platform to provide highly parallelized, efficient and ultra-fast single-photon detection. Waveguide integration enables the use of SNSPDs for photon counting, paving the way for high-performance and scalable photonic quantum computing. The Pixel Photonics team consists of 36 employees from 8 different countries.
Learn more about Pixel Photonics and the WI-SNSPD technology at www.pixelphotonics.com.
About Sparrow Quantum:
Sparrow Quantum, headquartered in Copenhagen, Denmark, is a leading provider of single-photon components enabling the photonic quantum revolution. Our flagship product, a deterministic single-photon source, sets industry standards and earns acclaim from leading quantum technology groups worldwide. With roots in over two decades of pioneering research at the Niels Bohr Institute, our technology seamlessly integrates with leading photonic quantum computing platforms and communication systems. Our dedication to advancing light-matter interfaces for quantum technologies ensures we deliver essential components for scaling up advanced quantum technology applications in information processing and communication.
Discover more about Sparrow Quantum at www.sparrowquantum.com.
About the Niels Bohr Institute, Copenhagen University:
At the Niels Bohr Institute, University of Copenhagen, we research and teach in a broad spectrum of physics areas: quantum computers and communication, astrophysics, particle physics, computational physics, solid state physics, climate and geophysics, and biophysics. In the past decade, our research in solid-state physics and quantum optics has continuously intensified with several new, large research centres. Among the latest is the Copenhagen Center for Biomedical Quantum Sensing, which will research in the development of ultra-sensitive sensors for the early detection of diseases. Last year, the Novo Nordisk Foundation Quantum Computing Program was also inaugurated, the goal of which is to develop a fully functional quantum computer within the next 12 years.
For more information, please visit www.nbi.ku.dk.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240313844049/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 06:30:00 CET | Press release
Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan
VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 01:00:00 CET | Press release
Enabling Next-Generation High-Performance Automotive Camera Systems VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise
Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 22:30:00 CET | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 22:30:00 CET | Press release
Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to
Multi-Color Corporation Receives Court Approval of First Day Motions4.2.2026 21:30:00 CET | Press release
Obtains Interim Approval to Access $125 Million of DIP FinancingGlobal Operations and Services to Customers Continue in Normal Course Without Interruption During Restructuring Process; All Trade Vendors and Suppliers to be Paid in Full Multi-Color Corporation (“MCC” or the “Company”), a global leader in prime label solutions, today announced that it has received approval from the U.S. Bankruptcy Court for the District of New Jersey (the “Court”) for first day relief related to its prepackaged Chapter 11 filed on January 29, 2026. The approved relief affirms that the Company will operate in the normal course, pay all trade vendors and suppliers in full, and maintain a strong liquidity position during the restructuring. As part of this relief, the Court granted MCC immediate access to $125 million of $250 million in debtor-in-possession (“DIP”) new money financing, provided by certain holders of MCC’s secured first lien debt and its equity sponsor, CD&R. This funding will capitalize the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
